Search Results 191-200 of 306 for ✍데이터기반 80211AC 성능저하가없다✍
They may seem harmless, but in this episode of Medical Edge Radio, Mayo Clinic Dr. Yvonne Romero explains some risks associated with antacids.
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma. Blood Cancer J. 2024 Oct 16; 14(1):180.
The purpose of this study is to evaluate safety and tolerability of multi-kinase inhibitor LNK01002 in patients with primary myelofibrosis (MF), or MF due to ...
About this study. A Phase 1, open-label, 3+3 dose escalation component to determine the safety, tolerability, PK, PD, and MTD of IV PRX004 when given as a ...
Publications. Pulukuri SV, Fagle TR, Trujillo-Rodriguez D, van Amerongen S, Bernick C, Geda YE, Wethe JV, Peskind ER, Katz DI, Alosco ML, Palmisano JN, ...
His research aims to determine how aging, sex and APOE isoforms influence cerebrovascular functions as well as disease development and progression using ...
About this study. This is an open-label, multi-center, dose escalation study of REGN1979 administered as an IV (intravenous) infusion.
The purpose of this study is to collect PillCamTM SB3 capsule endoscopy (CE) procedures and subsequent device-assisted enteroscopy (DAE) procedures data (double ...
The purpose of this study is to collect preliminary data related to the clinical utility of the SPEAC System in patients with a history of motor seizures. A ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.